Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma
NCT04728568
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Meningioma, Malignant
Interventions
DRUG:
Sintilimab
Sponsor
Beijing Tiantan Hospital